Literature DB >> 9839751

Topical antimicrobials applied to the umbilical cord stump: a new intervention against neonatal tetanus.

U D Parashar1, J V Bennett, J R Boring, W G Hlady.   

Abstract

BACKGROUND: Previous case-control studies of neonatal tetanus (NNT), a leading cause of infant mortality in developing countries, have suggested that antimicrobials applied after delivery to the umbilical cord stump may protect against this disease. However, assessment of their protective effect has been limited by the low prevalence of antimicrobial use in developing countries.
METHODS: We conducted a population-based, matched, case-control study to assess the use of antimicrobials and other factors potentially related to NNT in rural parts of Bangladesh. We studied 359 cases (infants who were normal at birth but who died between the 3rd and 30th day of life after an illness characterized by signs of NNT), each matched to three living controls for gender, residence, and date of birth.
RESULTS: In univariate analyses, the application of either antibiotics or disinfectants at delivery, and the continuous or any application of disinfectants were protective against NNT. The application of antibiotics at delivery (odds ratio [OR] = 0.21, P = 0.019), hand washing by the delivery attendant (OR = 0.64, P = 0.005), and prior maternal immunization with tetanus toxoid (OR = 0.50, P < 0.001) remained protective in conditional logistic-regression analyses. Application of animal dung to the umbilical stump (OR = 2.31, P = 0.047) was hazardous.
CONCLUSIONS: Effective and inexpensive topical antimicrobials provide a new prevention opportunity that could be used by traditional birth attendants and mothers to provide additional benefits to NNT control programmes based on maternal immunization with tetanus toxoid. Promotion of hygienic delivery and cord-care practices and increasing tetanus toxoid coverage remain cornerstones for the prevention of NNT deaths.

Entities:  

Keywords:  Age Factors; Antibiotics--therapeutic use; Asia; Bangladesh; Demographic Factors; Developing Countries; Diseases; Drugs; Infant; Infections; Population; Population Characteristics; Research Report; Southern Asia; Tetanus--prevention and control; Treatment; Youth

Mesh:

Substances:

Year:  1998        PMID: 9839751     DOI: 10.1093/ije/27.5.904

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  5 in total

1.  Risk factors for umbilical cord infection among newborns of southern Nepal.

Authors:  Luke C Mullany; Gary L Darmstadt; Joanne Katz; Subarna K Khatry; Steven C LeClerq; Ramesh K Adhikari; James M Tielsch
Journal:  Am J Epidemiol       Date:  2006-10-25       Impact factor: 4.897

Review 2.  Tetanus toxoid immunization to reduce mortality from neonatal tetanus.

Authors:  Hannah Blencowe; Joy Lawn; Jos Vandelaer; Martha Roper; Simon Cousens
Journal:  Int J Epidemiol       Date:  2010-04       Impact factor: 7.196

3.  Topical applications of chlorhexidine to the umbilical cord for prevention of omphalitis and neonatal mortality in southern Nepal: a community-based, cluster-randomised trial.

Authors:  Luke C Mullany; Gary L Darmstadt; Subarna K Khatry; Joanne Katz; Steven C LeClerq; Shardaram Shrestha; Ramesh Adhikari; James M Tielsch
Journal:  Lancet       Date:  2006-03-18       Impact factor: 79.321

Review 4.  Clean birth and postnatal care practices to reduce neonatal deaths from sepsis and tetanus: a systematic review and Delphi estimation of mortality effect.

Authors:  Hannah Blencowe; Simon Cousens; Luke C Mullany; Anne C C Lee; Kate Kerber; Steve Wall; Gary L Darmstadt; Joy E Lawn
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

5.  Effect of 4 % chlorhexidine on cord colonization among hospital and community births in India: a randomized controlled study.

Authors:  Sushma Nangia; Usha Dhingra; Pratibha Dhingra; Arup Dutta; Venugopal P Menon; Robert E Black; Sunil Sazawal
Journal:  BMC Pediatr       Date:  2016-08-02       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.